2Egermayer P, Town GI.The clinical significance of pulmonary embolism:uncertainties and implications for treatment debate[J]. J intern Med,1997,241:5-10.
5Anderson FA Jr, Wheeler HB, Goldberg RJ, et al.A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.Arch Intern Med,1991,151:933-938.
7Urokinase Pulmonary embolism trial: a national cooperative study. Circulation ,1973, 47:1-108.
8Goldhaber SZ, Kessler CM, Heit J, et al.Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.Lancet,1988,2:293-298.
9Goldhaber SZ. Evolving concepts in thrombolytic therapy for pulmonary embolism.Chest,1992,101(4 Suppl):183S-185S.
10Daniels LB, Parker JA, Patel SR, et al.Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism.Am J Cardiol, 1997,80:184-188.
